{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:11:15Z","timestamp":1780337475792,"version":"3.54.1"},"reference-count":114,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.2217\/pgs.16.22","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T23:59:53Z","timestamp":1464825593000},"page":"925-941","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Pharmacogenetics of Ribavirin-Induced Anemia in Hcv Patients"],"prefix":"10.1080","volume":"17","author":[{"given":"Antonio","family":"D'Avolio","sequence":"first","affiliation":[{"name":"Unit of Infectious Diseases, Department of Medical Sciences, Amedeo di Savoia Hospital, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Cusato","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Medical Sciences, Amedeo di Savoia Hospital, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"De Nicol\u00f2","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Medical Sciences, Amedeo di Savoia Hospital, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Allegra","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Medical Sciences, Amedeo di Savoia Hospital, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Perri","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Medical Sciences, Amedeo di Savoia Hospital, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,6]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392102"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392101"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2006.01228.x"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260231"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.025"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12162"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.06.005"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12170"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26978"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26602"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62401-6"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.01.005"},{"key":"e_1_3_3_14_1","unstructured":"FDA . Clinical pharmacology and biopharmaceutics review(s) ( 1998 ). www.accessdata.fda.gov\/drugsatfda_docs\/nda\/98\/20903_INTRON%20A%20REBETOL_BIOPHARMR.PDF ."},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp200647a"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009335002"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.7.3042"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.145854"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.10.4006-4008.2004"},{"key":"e_1_3_3_20_1","unstructured":"PubChem . www.pubchem.com ."},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00064-3"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31824bf778"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.12.038"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5789"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0020-711X(90)90140-X"},{"key":"e_1_3_3_26_1","volume-title":"14th International Workshop on Clinical Pharmacology of HIV Therapy","author":"De Nicol\u00f2 A","year":"2013","unstructured":"De Nicol\u00f2 A , CusatoJ , BoglioneLet al. Early ribavirin plasma concentrations as predictor of anemia onset after one month of anti-HCV therapy in ITPA stratified population . Presented at : 14th International Workshop on Clinical Pharmacology of HIV Therapy . Amsterdam, The Netherlands , March 2013 ."},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.04.016"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2013.11.027"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2013.02.025"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2012.03.030"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.04.038"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24636"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01780.x"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)30882-8"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e318272e55a"},{"key":"e_1_3_3_36_1","first-page":"495928","article-title":"Optimal erythrocyte ribavirin level to reduce the risk of anemia and obtain an early virological response in patients with chronic hepatitis C caused by genotype 1b infection","volume":"2010","author":"Kubota R","year":"2010","unstructured":"Kubota R , KomiyamaT , KumagaiNet al. Optimal erythrocyte ribavirin level to reduce the risk of anemia and obtain an early virological response in patients with chronic hepatitis C caused by genotype 1b infection . Hepat. Res. Treat.2010 , 495928 ( 2010 ).","journal-title":"Hepat. Res. Treat."},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv122"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.07.021"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08825"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.06.016"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-002-0798-z"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.059501"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.8.9.1221"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.06.071"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2010.00741.x"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24068"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.22069"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1796"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.40"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283546efd"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0579-y"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2251"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/v4081264"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2011.00927.x"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir754"},{"issue":"2","key":"e_1_3_3_56_1","first-page":"517","article-title":"Polymorphism of the inosine triphosphate pyrophosphatase gene predicts ribavirin-induced anemia in chronic hepatitis C patients","volume":"5","author":"Nishimura T","year":"2012","unstructured":"Nishimura T , OsakiR , ShioyaMet al. Polymorphism of the inosine triphosphate pyrophosphatase gene predicts ribavirin-induced anemia in chronic hepatitis C patients . Mol. Med. Rep.5 ( 2 ), 517 \u2013 520 ( 2012 ).","journal-title":"Mol. Med. Rep."},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i41.5879"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.11.027"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i9.1387"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12113"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2012.01637.x"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.4292\/wjgpt.v4.i3.54"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2013.28.8.1213"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23497"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.06.030"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12047"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23561"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12171"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27022"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.27148"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000123"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.5009\/gnl14095"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2015-0057"},{"issue":"2","key":"e_1_3_3_74_1","first-page":"38","article-title":"ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C","volume":"49","author":"Kucherenko A","year":"2015","unstructured":"Kucherenko A , PampukhaV , BobrovaI , MorozL , LivshitsL . ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C . Tsitol. Genet.49 ( 2 ), 38 \u2013 41 ( 2015 ).","journal-title":"Tsitol. Genet."},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760150104"},{"issue":"2","key":"e_1_3_3_76_1","first-page":"134","article-title":"Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment","volume":"23","author":"Zampino R","year":"2015","unstructured":"Zampino R , AlessioL , MarroneAet al. Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment . Infez. Med.23 ( 2 ), 134 \u2013 139 ( 2015 ).","journal-title":"Infez. Med."},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01564.x"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir665"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23302"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23323"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047725"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.129478"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6363984"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2014.10.030"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.11.99"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32834412e7"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S41127"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.02.035"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.01.019"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2014.11.007"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.18433\/J3DK6T"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2014.07.009"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir210"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095881"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.05.017"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12945"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12224"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku519"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.05.010"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1851"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-1069-9"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-015-3050-5"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2004.05.014"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328354455c"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114567"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.201110660"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1387.023"},{"key":"e_1_3_3_108_1","unstructured":"FDA . Table of pharmacogenomic biomarkers in drug labeling ( 2015 ). www.fda.gov\/Drugs\/ScienceResearch\/ResearchAreas\/Pharmacogenetics\/ucm083378.htm ."},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-015-2482-3"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.03.016"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08309"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.449"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020047"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1349"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2853"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs.16.22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:00:55Z","timestamp":1715983255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs.16.22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":114,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.2217\/pgs.16.22"],"URL":"https:\/\/doi.org\/10.2217\/pgs.16.22","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-07-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}